Pharmaceuticals, Biotechnology and Life Sciences
LEXINGTON, Mass.–(BUSINESS WIRE)–#LiverMtg19–Fractyl Laboratories Inc. (Fractyl) today announced positive results from the Revita-2 trial evaluating Revita DMR (duodenal mucosal resurfacing)…
— AI-Based Tools for Liver Histology Assessment Contribute to Gilead’s Broader Efforts to Improve Understanding of NASH — — Data…
PASADENA, Calif.–(BUSINESS WIRE)–$arwr–Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced Phase 2 clinical data on a double combination of JNJ-3989 (formerly…
Data Presented at the 2019 American College of Allergy, Asthma and Immunology Annual Meeting OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited…
—Despite Differing Study Designs, Patient Criteria and Geographies of the Two Landmark Clinical Trials, Results Were Consistent for AR101-Treated Patients…
Preclinical data support unique mechanism of action of ALPN-202 as a first in class conditional CD28 Agonist ALPN-202 able to…
HOUSTON–(BUSINESS WIRE)–Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today revealed that the logistical…
Joins Experienced Team to Accelerate Global Launch of the new Sonata® 2 System REDWOOD CITY, Calif.–(BUSINESS WIRE)–Gynesonics, a women’s healthcare…
Animal model operations to be transferred to Envigo ownership Divestment in line with Horizon’s corporate strategy to focus on its…
— Results being presented today in a late-breaking presentation (abstract TH-PO1201) at Kidney Week 2019, the annual meeting of the…